AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Choosing between ETF and mutual fund for retirement depends on tax efficiency and distribution patterns. We compare the two to help you pick the better option.
27,987 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
A public signaling push sets an August deadline for Bitcoin’s BIP-110 fork fight, forcing exchanges and miners to pla...
A record $182 billion in AI-focused bond issuance this year is fueling an infrastructure wave, but investors warn tha...
A mediated settlement ends a years-long dispute between NEXA Lending's CEO and its former partner, yielding full cont...
Dividend stocks paused last week as Crown Castle and AT&T tumbled while Coca-Cola rose. The move highlights a cooling...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
Bitcoin trader and former BitMEX catalyst Arthur Hayes is sticking to a bold forecast: a multi-hundred-thousand-dolla...
Recalls are part of the auto business, but the year, same ford problem: can still test investors. This article breaks...
New guidance on supplement timing says the best time take your vitamins depends on vitamin type and possible interact...
Credit card points can unlock amazing travel, big statement credits, and even once in a lifetime experiences. This gu...
The Home Depot is rolling out AI-powered planning and project-management tools for professional builders, aiming to s...
U.S. stocks edged higher for the week even as oil prices surged, propelled by resilient corporate results and bets th...